Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.
Clinical trial NCT06304818 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06304818
- Sponsor
- Sinocelltech Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2027-12-30
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.